Amorphis Pharma Development
KRSCompany age:
Age:
6 y. 11 m. 27 d.
Share capital:
Share capital:
5 000 PLN
Company Amorphis Pharma Development
Company suspended its operations from 2024-01-01
KRS
0000760620
NIP
9542799406 (Niezarejestrowany)
REGON
38192563600000
| Address | UL. BANKOWA 12-147, PL-40-007, KATOWICE | |
| Voivodeship | Silesian |
Add to phone
Scan the QR code to add the company’s contact details directly to your phone.
Management
Kubajczyk Martyna Elżbieta, prezes zarządu
Beneficiaries of
1 beneficiary
More ›
| Rating | |||
| Main industry | Manufacture of basic pharmaceutical products | ||
PKD codes:
21.10.Z - Manufacture of basic pharmaceutical products
10.89.Z - Manufacture of other food products not elsewhere classified
20.13.Z - Manufacture of other inorganic basic chemicals
21.20.Z - Manufacture of pharmaceutical preparations
46.46.Z - Wholesale of pharmaceutical and medical goods
70.22.Z - Business and other management consultancy activities
72.1 - Research and experimental development on natural sciences and engineering
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
AMORPHIS PHARMA DEVELOPMENT was established on 2018-11-30 and is currently located at UL. BANKOWA 12-147, PL-40-007, KATOWICE. Company suspended its operations from 2024-01-01. The main activity of the company is production of pharmaceutical substances. Other activities carried out by the company include manufacture of basic pharmaceutical products, manufacture of other food products not elsewhere classified, manufacture of other inorganic basic chemicals, manufacture of pharmaceutical preparations, wholesale of pharmaceutical and medical goods and others. As per the latest entry in the National Court Register, the current management board of the company comprises 1 individual(s). The most recent update in the National Court Register was recorded on 2024-06-28.